[Some advances in angiotensin converting enzyme inhibitors].
D000804:Angiotensin II / Q000096:biosynthesis; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D002216:Captopril / Q000494:pharmacology / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D009842:Oligopeptides / Q000032:analysis / Q000502:physiology / Q000627:therapeutic use; D011453:Prostaglandins / Q000502:physiology; D012595:Scleroderma, Systemic / Q000188:drug therapy; D013329:Structure-Activity Relationship; D013722:Teprotide
D000806:Angiotensin-Converting Enzyme Inhibitors; D009842:Oligopeptides; D011453:Prostaglandins; D000804:Angiotensin II; D002216:Captopril; D013722:Teprotide